Results 161 to 170 of about 217,698 (299)
What's New? Anal squamous cell carcinoma (ASCC) incidence is increasing, with most cases occurring in immunocompetent women. ASCC risk is linked in particular to genital human papillomavirus (HPV) infection and HPV‐associated high‐grade squamous intraepithelial lesions (HSILs).
Isabel Matas +13 more
wiley +1 more source
Towards Tunable Graphene/Phthalocyanine–PPV Hybrid Systems
Malig J. +6 more
openaire +3 more sources
Although immune checkpoint inhibitors (ICI) have transformed metastatic melanoma treatment, thromboembolic events (TEEs) remain a serious complication. Moreover, existing risk assessment models were developed prior to ICI use and lack clinical validation.
Tim Zell +12 more
wiley +1 more source
Application of HEART, GRACE 2.0 and TIMI scores for risk stratification of chest pain: a single-centre external pilot study in a Sri Lankan population. [PDF]
Welhenge C +6 more
europepmc +1 more source
Abstract Objective Birth asphyxia is one of the leading causes of death for neonates worldwide. Lack of an objective cost effective test to predict poor newborn outcomes at birth affects the ability to respond appropriately. This study determined predictive values of umbilical cord arterial lactate in relation to adverse neonatal outcomes. Methods This
Elizabeth Ayebare +7 more
wiley +1 more source
Establishment of a TaqMan-based quantitative real-time PCR for the detection of porcine parvovirus. [PDF]
Hu Z +10 more
europepmc +1 more source
Abstract Objective To evaluate the practicability of self‐collected tampons with the MPap assay for endometrial cancer (EC) detection, by comparing with the results of cervical swabs. Methods A total of 85 women at Tri‐Service General Hospital (TSGH) were included to directly compare the performance of physician‐collected swabs and self‐collected ...
Kuo‐Min Su +5 more
wiley +1 more source
Clinical efficacy of Conbercept combined with pars plana vitrectomy for proliferative diabetic retinopathy. [PDF]
Chen Y, Wang M, Gao J.
europepmc +1 more source

